ストックスクリーナーアプリを入手
19.91
2.55%
-0.52
アフターアワーズ：
19.91
Rigel Pharmaceuticals (RIGL) 最新ニュース
Rigel Pharmaceuticals’ SWOT analysis: pipeline potential drives stock outlook - Investing.com
Rigel Pharmaceuticals’ SWOT analysis: pipeline potential drives stock outlook By Investing.com - Investing.com UK
Rigel Looks Interesting, But Let's Wait For A Lower Price (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia
Rigel Pharmaceuticals adds oncology expert to board By Investing.com - Investing.com Australia
SEC Form 4 filed by Director Frohlich Mark W - Quantisnow
Rigel Pharmaceuticals appoints new board member - Investing.com
Rigel Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update - Quantisnow
Rigel Pharmaceuticals Appoints Dr. Frohlich to Board - TipRanks
Rigel appoints Mark W. Frohlich to its board -March 10, 2025 at 12:01 pm EDT - Marketscreener.com
Rigel Pharmaceuticals appoints Mark W. Frohlich to board of directors - MSN
Rigel Pharmaceuticals adds oncology expert to board - Investing.com India
Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors - StockTitan
Rhumbline Advisers Has $423,000 Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
FY2025 EPS Estimates for RIGL Increased by Cantor Fitzgerald - Defense World
Citigroup Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal - MSN
Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded by StockNews.com to “Buy” - Defense World
What is B. Riley’s Forecast for RIGL Q1 Earnings? - Defense World
What is HC Wainwright’s Estimate for RIGL Q1 Earnings? - Defense World
Earnings call transcript: Rigel Pharmaceuticals Q4 2024 sees strong growth By Investing.com - Investing.com Australia
Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
Rigel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World
HC Wainwright Reiterates Buy Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) - Defense World
What is B. Riley’s Estimate for RIGL FY2026 Earnings? - Defense World
Q3 Earnings Forecast for RIGL Issued By HC Wainwright - Defense World
Rigel Pharmaceuticals price target raised to $55 from $49 at Citi - TipRanks
Rigel Pharmaceuticals Reports Record Sales and Strategic Growth - TipRanks
Wall Street Analysts Believe Rigel (RIGL) Could Rally 44.93%: Here's is How to Trade - Nasdaq
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2024 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals stock holds Buy rating, $57 target By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals stock holds Buy rating, $57 target - Investing.com India
B. Riley Raises Price Target on Rigel Pharmaceuticals to $24 From $20, Keeps Neutral Rating - Marketscreener.com
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Malaysian Reserve
Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates - MSN
Rigel: Q4 Earnings Snapshot - Midland Daily News
Rigel Pharmaceuticals Inc (RIGL) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Rigel Pharmaceuticals Reports Strong 2024 Financial Results - TipRanks
Earnings call transcript: Rigel Pharmaceuticals Q4 2024 sees strong growth - Investing.com India
Rigel Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Rigel: Q4 Earnings Snapshot -March 04, 2025 at 05:34 pm EST - Marketscreener.com
Rigel Pharmaceuticals Q4 Earnings: EPS of $0.81 and Revenue of $57.6M Surpass Estimates - GuruFocus.com
Rigel Pharmaceuticals Inc. Q4 Profit Advances - Nasdaq
Rigel Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Rigel Pharmaceuticals reports Q4 EPS 80c, consensus 58c - TipRanks
0.49%
1.87%
大文字化:
|
ボリューム (24 時間):